Moneycontrol PRO
HomeAuthorVaibhavi ranjan

Vaibhavi Ranjan

Correspondent

Moneycontrol

India or China? Macquarie finds the battle tough, but India takes an edge

BUSINESS

India or China? Macquarie finds the battle tough, but India takes an edge

Macquarie finds the choice between India and China challenging as China’s stimulus plans sparks hopes of revival despite persisting structural issues. However, India’s stronger fundamentals, with steady 6-7% GDP growth and robust corporate ROEs, continue to tilt the balance in its favor.

Nifty, Sensex off to a jittery start ahead of major earnings; auto stocks take a hit

BUSINESS

Nifty, Sensex off to a jittery start ahead of major earnings; auto stocks take a hit

The market, having consolidated for the past few weeks, is expected to be driven by earnings performances due to a lack of other significant triggers.

Uncertainty over China stimulus leaves metal stocks in a state of flux; clarity to reignite momentum

BUSINESS

Uncertainty over China stimulus leaves metal stocks in a state of flux; clarity to reignite momentum

The uncertainty around China's stimulus has left metal stocks volatile, with investors awaiting clearer economic revival plans. While hopes for stronger measures still hold ground, analysts believe a sustained rally in metal stocks hinges on definitive government actions.

Analyst Call Tracker: Divi's Labs wins back favour after Nifty 50 departure

BUSINESS

Analyst Call Tracker: Divi's Labs wins back favour after Nifty 50 departure

While supply chain diversification and the US Biosecure Act can help Divi's target the $800 million revenue opportunity from GLP-1 APIs, many brokerages also warned that these narratives are unlikely to materialise as quickly as investors expect.

Q2 FY25 to see slowest earnings growth in 17 qtrs as high base, demand slump take toll

BUSINESS

Q2 FY25 to see slowest earnings growth in 17 qtrs as high base, demand slump take toll

The BFSI sector is expected to drive Q2 earnings growth for Nifty yet again, albeit not with the same mojo. Global-facing sectors such as IT, pharma, and chemicals are likely to provide additional support, while growth in automobiles, industrials, and commodities may slow down.

Metal stocks melt as China state planner's stimulus plans disappoint, iron ore prices tumble

BUSINESS

Metal stocks melt as China state planner's stimulus plans disappoint, iron ore prices tumble

China's National Development and Reform Commission (NDRC) disappointed investors by withholding major new stimulus measures, despite expressing confidence in meeting the country's economic target for the year.

Nifty, Sensex extend downturn to sixth session, broader market bleeds

BUSINESS

Nifty, Sensex extend downturn to sixth session, broader market bleeds

The Indian benchmarks bucked the positive global trend and dived in the red as investors dwindled with concerns over outflows to China, Q2 earnings growth moderation and geopolitical tensions in the Middle East.

MOFSL forecasts Q2FY25 to deliver slowest Nifty earnings growth in 17 quarters

BUSINESS

MOFSL forecasts Q2FY25 to deliver slowest Nifty earnings growth in 17 quarters

After four exciting years of double-digit growth, India Inc's earnings are expected to hit the brakes for a bit. According to MOFSL, this moderation is due to a mix of rising commodity pressures, dwindling tailwinds from improved BFSI asset quality, a high base, and a slight ease in demand.

Short Call | Metals bask in the hopes of China's revival; M&M, Avenue Supermarts in focus

BUSINESS

Short Call | Metals bask in the hopes of China's revival; M&M, Avenue Supermarts in focus

“In cyclicals, a period of silly prices is followed by a period of sobriety.” -- Peter Lynch

Risk-off sentiment abounds in India amid geopolitical unrest, China's revival; here's where investors could find shelter

BUSINESS

Risk-off sentiment abounds in India amid geopolitical unrest, China's revival; here's where investors could find shelter

Amidst the prevailing uncertainties in the market, analysts suggest investors to take shelters in domestic focused sectors while warning that investments still need to be stock specific.

UBS initiates 'sell' calls on slew of pharma majors; sees growth slowdown in India & US mkts

BUSINESS

UBS initiates 'sell' calls on slew of pharma majors; sees growth slowdown in India & US mkts

UBS initiated 'sell' calls on Dr Reddy's Laboratories Lupin, Aurobindo Pharma and Zydus Lifesciences while picking Sun Pharma and Cipla as its preferred bets in the pharmaceutical sector.

Short Call: US dollar on a bumpy road, but not every currency will cash in the rough ride; BHEL, Skipper, Aadhar Housing Finance in focus

BUSINESS

Short Call: US dollar on a bumpy road, but not every currency will cash in the rough ride; BHEL, Skipper, Aadhar Housing Finance in focus

"The four most dangerous words in investing are, it’s different this time." —Sir John Marks Templeton 

Slowdown in urban consumption or change in preference? CLSA explains

BUSINESS

Slowdown in urban consumption or change in preference? CLSA explains

Urban consumption trends, especially among young Indians, point to a shift in preferences towards experiences like events, dining out, travel, luxury and premium goods, fast fashion, cosmetics, and consumer electronics—leaving fries and pizzas behind.

With markets at all-time highs, defensive plays gain favour

BUSINESS

With markets at all-time highs, defensive plays gain favour

Over the past week, the rally in PSU stocks has cooled off significantly, with the BSE PSU index sliding nearly 4%. Meanwhile, defensive sectors have gained momentum, with the BSE FMCG and BSE Healthcare indices rising around 2%.

Kalyan Jewellers surges 4% to record high; HSBC raises price target

BUSINESS

Kalyan Jewellers surges 4% to record high; HSBC raises price target

Kalyan Jewellers shares are currently trading at a 10 percent valuation discount as compared to industry rival Titan, making it a lucrative buy for investors looking at the jewellery segment.

Short Call: Rush to buy gold, but what are investors running from? CEAT, ONGC, Dixon Tech in focus

BUSINESS

Short Call: Rush to buy gold, but what are investors running from? CEAT, ONGC, Dixon Tech in focus

“Gold, much more so than any other commodity, is about sentiment and psychology.”—Peter Lynch​

Piramal Pharma stock surges to record high on heavy volumes, strong growth prospects

BUSINESS

Piramal Pharma stock surges to record high on heavy volumes, strong growth prospects

The passage of the draft US Biosecure Act has ushered a wave of optimism for Indian CDMO players in hopes of more work coming their way as US drugmakers look to shift manufacturing bases out of China.

Upstream oil majors drop as much as 5% after Brent crude slips below $70

BUSINESS

Upstream oil majors drop as much as 5% after Brent crude slips below $70

Brent crude prices dipped below $70 per barrel overnight for the first time since December 2021, as worries about sluggish demand, slowing economic growth, and the increasing shift towards electric vehicles weighed on the sentiment.

The coming booster for Indian pharma stocks: US Biosecure Act

BUSINESS

The coming booster for Indian pharma stocks: US Biosecure Act

The US Biosecure Act aims to prohibit US drugmakers from engaging in business with five Chinese companies after eight years.

Analyst Call Tracker Aug 2024: Apollo Hospitals falls out of favour in last one month despite upbeat growth narrative

BUSINESS

Analyst Call Tracker Aug 2024: Apollo Hospitals falls out of favour in last one month despite upbeat growth narrative

Despite delivering better-than-expected results that gave investors plenty to rejoice, Apollo Hospitals stock still managed to snag the top spot on Moneycontrol's list of most downgraded stocks over the past month. Quite the plot twist!

OMC and paint stocks cheer for fall in crude prices while ONGC and Oil India sulk into red

BUSINESS

OMC and paint stocks cheer for fall in crude prices while ONGC and Oil India sulk into red

The fall in Brent crude prices is a double-edged sword in the stock market, benefiting some sectors while hurting others.

Morgan Stanley upgrades PI Industries but Aarti Industries gets a downgrade

BUSINESS

Morgan Stanley upgrades PI Industries but Aarti Industries gets a downgrade

Morgan Stanley has raised price targets for some chemical stocks but also warned that the sector's earnings have not yet been fully de-risked.

Why is SEBI facing flak over ICICI Bank-ICICI Securities merger case? | Explained

BUSINESS

Why is SEBI facing flak over ICICI Bank-ICICI Securities merger case? | Explained

SEBI's handling of the merger between ICICI Bank and ICICI Securities has raised eyebrows, with many investors questioning the regulator's leniency in allowing the bank to bypass its own rules.

Disparity in US stock performances gives hedge funds edge to cherry-pick and boost returns: Morgan Stanley

BUSINESS

Disparity in US stock performances gives hedge funds edge to cherry-pick and boost returns: Morgan Stanley

Morgan Stanley notes that hedge funds' have an advantage in generating both long and short alpha, thanks to their flexible approach compared to traditional benchmarks. This unconstrained strategy positions them well to achieve better returns in a market increasingly influenced by stock-specific performances.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347